Diclazuril

Diclazuril (R-64433), a benzeneacetonitrile derivative, is a potent and orally active anticoccidial agent. Diclazuril can be used for the research of certain infectious and parasitic diseases, including coccidiosis, acute toxoplasmosis, equine protozoal pyoencephalitis (EPM) et.al[1][2].

Product Specifications

CAS Number

[101831-37-2]

Product Name Alternative

R-64433

UNSPSC

12352005

Hazard Statement

H400

Target

Antibiotic; Parasite

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/diclazuril.html

Purity

99.70

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

O=C(NC1=O)N(N=C1)C2=CC(Cl)=C(C(C#N)C3=CC=C(Cl)C=C3)C(Cl)=C2

Molecular Formula

C17H9Cl3N4O2

Molecular Weight

407.64

Precautions

H400

References & Citations

[1]Diaferia, M., et al., Efficacy of toltrazuril 5 % suspension (Baycox (R), Bayer) and diclazuril (Vecoxan (R), Janssen-Cilag) in the control of Eimeria spp. in lambs. Parasitol Res, 2013. 112 Suppl 1: p. 163-8.|[2]http://www.huvepharma.com/products/view/190